JAK2 and leukemia: Since in vitro differentiation of hiPSCs toward B-lymphoid cells remains a challenging task, we aimed to investigate a JAK2 fusion, which occurs in leukemia of the myeloid and lymphoid lineages, and whose expression is driven by an N-terminal partner at the onset of hematopoietic development.